Role of Seizures in Alzheimer's Disease is Gaining Overdue Attention
Evidence suggests that such abnormal electrical activity may occur much earlier than signs of memory loss
Stories by STAT
The Psychedelics Evangelist: A German Financier Wants to Turn Magic Mushrooms into Modern Medicine
One company the entrepreneur invests in wants to develop psilocybin in a lab—so no need to extract it from mushrooms
Fed Up with Washington, ALS Advocates Consider ACT UP's Take-No-Prisoners Approach
Patients want drugs fast-tracked through FDA approval process
Congress Revives Ban on Altering the DNA of Human Embryos Used for Pregnancies
Some scientists had called for lifting the ban to allow the U.S. Food and Drug Administration to evaluate the new technologies
Is $2.1 Million Too Much for a Drug? For Affected Parents, There Is No Debate
Similarly effective drugs in the pipeline will also be gauged against their enormous price tags
At First-Ever Public Hearing on CBD, FDA and Advocates Try to Blaze Trail to Regulatory Compromise
Agency officials press sometimes confused stakeholders for more data. Is it possible to define a “more effective CBD cosmetic?”
U.S. Measles Cases Top 700 This Year as Health Officials Urge Vaccinations
The surge in cases has sent 66 children to the hospital, according to the Centers for Disease Control and Prevention
Stanford Clears Three Faculty Members of "CRISPR Babies" Involvement
A review concluded that the scientists did not take part in a Chinese researcher’s experiment to edit the genomes of twin human embryos
The Case of a Woman Who Feels Almost No Pain Leads Scientists to a New Gene Mutation
The discovery may have implications for treating acute and chronic pain
Biogen Halts Studies of Closely Watched Alzheimer's Drug, a Blow to Hopes for New Treatment
Trial failure raises doubts about amyloid as a target for drug development
FDA Approves First New Drug Developed for Women with Postpartum Depression
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
New Acting FDA Commissioner Named
Ned Sharpless, director of the National Cancer Institute, will take over the job when Scott Gottlieb leaves next month
FDA Approves Esketamine, the First Major Depression Treatment to Reach U.S. Market in Decades
Nasal spray related to the anesthetic/street drug ketamine targets treatment-resistant patients
A Second Person Has Been Effectively "Cured" of HIV
10 years after the so-called “Berlin Patient,” a second man has been put into sustained remission
Time's Up Tackles Gender Bias and Harassment in Health Care
The nonprofit is launching a new affiliate to address these issues, with the backing of major medical institutions
FDA Issues Warning about Young-Blood Transfusions
Plasma from young people offers “no proven clinical benefit” as a treatment against aging or Alzheimer’s disease, the agency says
Silicon Valley Start-Up Hopes to Deliver Precision Cancer Medicine to Dogs
Promoters hope efforts will also offer insights into treatments used for humans
Ebola Vaccine Supplies Are Expected to Last
The World Health Organization predicts the Democratic Republic of the Congo has enough of the experimental vaccine
NIH Plans to Spend Up to $20 Million on Search for Alternatives to Fetal Tissue for Research
The preliminary announcement comes in the wake of a Trump administration order that agency scientists to stop buying such tissue from humans
Chinese Scientist Claims First Gene-Edited Babies Born
In a YouTube video, the researcher announced the birth of twin girls whose genomes he says were modified with CRISPR to prevent HIV infection
